General
Preferred name
CISATRACURIUM
Synonyms
CISATRACURIUM BESYLATE ()
51W89 ()
Nimbex ()
atracurium besilate ()
Cisatracurium Besylate ()
Cisatracurium (besylate) ()
51W89 (besylate) ()
Cisatracurium (besilate) ()
51-W89 ()
Nimbex preservative free ()
Cisatracurium (as besilate) ()
Cisatracurium besilate ()
51-W-89 ()
51 W89 ()
51W-89 ()
Cisatracurium besylate preservative free ()
Cisatracurium ion ()
Cisatracurium cation ()
P&D ID
PD013318
CAS
96946-42-8
96946-41-7
Tags
available
drug
Approved by
FDA
First approval
1995
Drug Status
investigational
approved
Drug indication
Muscle spasm
Neuromuscular Blocking Agent
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
18
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
53
Properties
(calculated by RDKit )
Molecular Weight
928.51
Hydrogen Bond Acceptors
12
Hydrogen Bond Donors
0
Rotatable Bonds
24
Ring Count
6
Aromatic Ring Count
4
cLogP
8.07
TPSA
126.44
Fraction CSP3
0.51
Chiral centers
4.0
Largest ring
6.0
QED
0.04
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
nicotinic acetylcholine receptor antagonist
acetylcholine receptor antagonist
Target
Muscle-type nicotinic acetylcholine receptor
AChR
Adrenergic Receptor
CHRNA2
nAChR
Pathway
Neuroscience
GPCR/G protein
Autophagy
Membrane Transporter/Ion Channel
Neuronal Signaling
Indication
muscle relaxant, endotracheal intubation
Disease Area
neurology/psychiatry, critical care
Biosynthetic Origin
Alkaloid
Therapeutic Indication
Muscle Relaxant
Therapeutic Class
CNS & PNS
Source data